Phase 3 Psoriasis Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are willing to sign a consent form before any study-related procedures begin
• People who have been diagnosed with psoriatic arthritis according to the 2006 CASPAR classification standard at the time of screening
• People whose psoriatic arthritis is currently active (meaning symptoms are ongoing) at the time of joining the study
• People who currently have at least one plaque psoriasis skin lesion, or who have had plaque psoriasis in the past
• People whose psoriatic arthritis remains active despite having previously been treated with certain standard disease-modifying or anti-inflammatory medications (csDMARDs and/or NSAIDs)

Who may not be able to join:

• People with certain other medical conditions, including drug-induced psoriasis, other active inflammatory or autoimmune diseases, a history of organ transplantation, a history of lymphocyte-related blood conditions, or a history of severe infections
• People who have received certain psoriatic arthritis or psoriasis treatments within a specific period before the study, such as injections into the joints or herbal/plant-based preparations (confirm with trial site for exact timeframes)
• People who have a known allergy to any ingredient in the study drug, or who have had allergic reactions to other biological medications
• People who are pregnant or breastfeeding, or who have a history of alcohol or illegal drug misuse

Important: Always verify eligibility with the trial site directly before applying.